Depression: An Important Risk Factor for Cognitive Decline
|
|
- Terence Lang
- 6 years ago
- Views:
Transcription
1 Depression: An Important Risk Factor for Cognitive Decline No conflicts of interest Sarah K. Tighe, M.D. Assistant Professor University of Iowa Carver College of Medicine Department of Psychiatry Institute of Medicine Public Health Dimensions of Cognitive Aging April 11, 2014
2 Objectives 1. Impact of depression on cognitive decline 2. Prevention and treatment for depression-related cognitive decline 3. Gaps in current knowledge Sperling et al., Alzheimer s & Dementia, 2011
3 Major depression: most common mental illness in U.S. GAD: Generalized anxiety disorder PTSD: Post-traumatic stress disorder ADHD: Attention deficit hyperactivity disorder ODD: Oppositional defiant disorder Kessler et al., Arch Gen Psychiatry 2005
4 Depression increases dementia risk Da Silva et al., British Journal of Psychiatry 2013
5 Depression is heterogeneous across adulthood Highly variable clinical presentation Age of onset Symptomatology Illness course Important implications for study of cognitive outcomes Timing of depression matters
6 Timing of depression effects cognitive decline Timing of depression Early onset depression (EOD) < 65 years* Late-life depression (LLD) > 65 years* *Variable cutoff
7 EOD and LLD increase dementia risk through different mechanisms 1. EOD is a risk factor for cognitive decline Early onset depression Neuropathology Cognitive decline 2. LLD is a prodrome of cognitive decline Age-related pathologic process Late-life depression Cognitive decline EOD: Early onset depression LLD: Late-life depression Butters et al., Dialogues Clin Neurosci 2008; Byers and Yaffe. Nat Rev Neurol 2011
8 EOD and LLD increase dementia risk through different mechanisms 1. EOD is a risk factor for cognitive decline Early onset depression Neuropathology Cognitive decline EOD: Early onset depression LLD: Late-life depression Butters et al., Dialogues Clin Neurosci 2008; Byers and Yaffe. Nat Rev Neurol 2011
9 Dementia risk increases with number of EOD episodes EOD: Early onset depression Dotson et al., Neurology 2010
10 Reduced hippocampal volumes in EOD EOD: Early onset depression Sheline et al., J Neurosci 1999
11 Inflammation Increased glucocorticoids Impaired neurogenesis Disrupted growth factors Theoretical pathway 1 Early onset depression Hippocampal atrophy Cognitive decline Butters et al., Dialogues Clin Neurosci 2008; Byers and Yaffe. Nat Rev Neurol 2011
12 Antidepressant treatment associated with larger hippocampal volumes in EOD * * p=0.08 Huang, et al. Biol Psychiatry 2013
13 EOD and LLD increase dementia risk through different mechanisms 2. LLD is a prodrome of cognitive decline Age-related pathologic process Late-life depression Cognitive decline EOD: Early onset depression LLD: Late-life depression Butters et al., Dialogues Clin Neurosci 2008; Byers and Yaffe. Nat Rev Neurol 2011
14 LLD increases dementia risk nearly 2-fold Meta-analysis of 23 studies Age 50+ years at baseline LLD associated with significant risk of all-cause dementia (1.85, 95% CI ) Diniz et al., British Journal of Psychiatry 2013
15 LLD associated with increased WMHs White matter hyperintensities Brain marker of vascular disease Associated with cognitive decline and dementia Roughly 2 times more common in LLD than controls WMHs: White matter hyperintensities Debette and Markus, BMJ 2010; Taylor et al., Molecular Psychiatry 2013
16 Theoretical White matter hyperintensities pathway 2 Vascular disease Late-life depression Cognitive decline Butters et al., Dialogues Clin Neurosci 2008; Byers and Yaffe. Nat Rev Neurol 2011
17 Standard LLD treatment is suboptimal for mood and cognition Cognitive impairment often persists despite remission of depression Addition of donepezil to anti-depressant treatment increases risk of LLD recurrence In elders with Alzheimer s dementia, greater exposure to psychotropic medications was associated with more rapid cognitive and functional decline Bhalla et al., Am J Geri Psych 2006; Reynolds et al., Arch Gen Psych 2011; Rosenberg et al., Int J Geri Psych 2012
18 Early evidence that statins have a protective effect against depression Parsaik et al. Journal of Affective Disorders 2014
19 Gaps in current knowledge Refine important terms Age cutoff for LLD Enrich phenotypes Several disease mechanisms Incorporate biomarkers (CSF, MRI, PET)
20 Gaps in current knowledge Effect of treating mid-life vascular disease risk factors on LLD Include depression as outcome measure vascular disease studies Better understanding of mechanisms to guide development of prevention strategies and rational therapeutics Needed for mood and cognitive symptoms Examine impact of other chronic mental illnesses on cognitive decline Autism Psychiatric comorbidity (e.g. substance use disorders + depression)
Depression and cognitive decline in later life: cause, consequence or co-morbidity?
Depression and cognitive decline in later life: cause, consequence or co-morbidity? Damien Gallagher MB MD MRCPsych Geriatric Psychiatrist, Sunnybrook Health Sciences Centre, Assistant Professor, University
More informationAnxiety, Depression, and Dementia/Alzheimer Disease: What are the Links?
The 2016 Annual Public Educational Forum Anxiety, Depression, and Dementia/Alzheimer Disease: What are the Links? Mary Ganguli MD MPH Professor of Psychiatry, Neurology, and Epidemiology, University of
More informationMild Cognitive Impairment (MCI)
October 19, 2018 Mild Cognitive Impairment (MCI) Yonas E. Geda, MD, MSc Professor of Neurology and Psychiatry Consultant, Departments of Psychiatry & Psychology, and Neurology Mayo Clinic College of Medicine
More informationNeurobiology of Depression
Chapter 1 Neurobiology of Depression Depression can affect every aspect of life. A patient undergoing a major depressive episode who receives treatment with any antidepressant will often experience symptomatic
More informationMood swings in young people
Mood swings in young people Bipolar I & II Disorders are uncommon before puberty; Mood Dysregulation (MD) is very common before puberty Are they the same problem? What are the beginnings of bipolar? What
More informationThe Neurobiology of Psychiatric Disorders
The Neurobiology of Psychiatric Disorders Vikaas S. Sohal, MD PhD Department of Psychiatry Center for Integrative Neuroscience Sloan Swartz Center for Theoretical Neurobiology Overview 1. Classification
More informationAttention-Deficit/Hyperactivity Disorder Nathan J. Blum, M.D.
ADHD in Preschool Children Preschool ADHD: When Should We Diagnose it & How Should We Treat it? Professor of Pediatrics Diagnosis of ADHD in Preschool Children: Impact of DSM-IV Is Preschool ADHD Associated
More informationChildhood ADHD is a risk factor for some Psychiatric Disorders and co-morbidities
Childhood ADHD is a risk factor for some Psychiatric Disorders and co-morbidities By: Dr. Ehsane M. Gad M.B.B.Ch CABMSPsych. D.P.P Post-Fellow Aus. Consultant Child Psychiatry Childhood ADHD and emergence
More information9/29/2011 TRENDS IN MENTAL DISORDERS. Trends in Child & Adolescent Mental Health: What to look for and what to do about it. Autism Spectrum Disorders
Trends in Child & Adolescent Mental Health: What to look for and what to do about it. Jason J. Washburn, Ph.D., ABPP Director, Center for Evidence-Based Practice TRENDS IN MENTAL DISORDERS Autism Spectrum
More informationRational Medication Use in Dementia
Rational Medication Use in Dementia Stephen Thielke sthielke@u.washington.edu (206) 764 2815 I have no conflicts of interest to report. I am an employee of the federal government. The opinions in this
More informationKey Messages. Around 20% of children and adolescents are estimated to have mental health disorders or problems
Key Messages Around 20% of children and adolescents are estimated to have mental health disorders or problems In a young person presenting with mental health problems, assessment of suicide risk should
More informationTrends in Child & Adolescent Mental Health: What to look for and what to do about it.
Trends in Child & Adolescent Mental Health: What to look for and what to do about it. Jason J. Washburn, Ph.D., ABPP Director, Center for Evidence-Based Practice TRENDS IN MENTAL DISORDERS 1 Autism Spectrum
More informationOutline of Lecture 2/13/2018
Allan I. Pack, M.B.Ch.B., Ph.D., FRCP John Miclot Professor of Medicine Director, Center for sleep and Circadian Neurobiology University of Pennsylvania Perelman School of Medicine Philadelphia, Pennsylvania
More informationMoving Targets: An Update on Diagnosing Dementia in the Clinic
Moving Targets: An Update on Diagnosing Dementia in the Clinic Eric McDade DO Department of Neurology School of Medicine Alzheimer Disease Research Center Disclosures No relevant financial disclosures
More informationWORKBOOK ANSWERS CHAPTER 14 MENTAL DISORDERS
WORKBOOK ANSWERS CHAPTER 14 MENTAL DISORDERS 1. POSTTRAUMATIC STRESS DISORDER SHORT ANSWERS 2. ALZHEIMER DISEASE 3. STRESS IS CONSIDERED A CONTRIBUTING FACTOR CAUSING EXACERBATION OF MENTAL DISORDERS.
More informationImaging of Alzheimer s Disease: State of the Art
July 2015 Imaging of Alzheimer s Disease: State of the Art Neir Eshel, Harvard Medical School Year IV Outline Our patient Definition of dementia Alzheimer s disease Epidemiology Diagnosis Stages of progression
More informationMental Health Current Articles Bulletin - April 2018
Library and Knowledge Services Mental Health Current Articles Bulletin - April 2018 How to Obtain an Article If you would like to request any articles included in this bulletin, or to be put onto the bulletin
More informationNeuropsychiatric symptoms as predictors of MCI and dementia: Epidemiologic evidence
16th Annual MCI Symposium January 20, 2018 Miami, FL Neuropsychiatric symptoms as predictors of MCI and dementia: Epidemiologic evidence Yonas E. Geda, MD, MSc Professor of Neurology and Psychiatry Consultant,
More informationJune 2015 MRC2.CORP.D.00030
This program is paid for by Otsuka America Pharmaceutical, Inc. and Lundbeck, LLC. The speaker is a paid contractor of Otsuka America Pharmaceutical, Inc. June 2015 MRC2.CORP.D.00030 advice or professional
More informationFDA Perspective on Disease Modification in Schizophrenia
FDA Perspective on Disease Modification in Schizophrenia Robert Levin, M.D. Clinical Team Leader Division of Psychiatry Products Food and Drug Administration Goals and Expectations Develop treatments that
More informationD I A G N O S I S ADD/ADHD. Conduct Disorder. Oppositional. Oppositional Defiant Disorder. Defiant. Anxiety Disorder. Adjustment.
Dr. Crismon has no potential conflicts of interest to disclose with regard to this presentation. M. Lynn Crismon, Pharm.D., FCCP, BCPP Dean James T. Doluisio Regents Chair & Behrens Centennial Professor
More informationAre Behavioural Disorders a separate nosological category of disorders?
249 Review Article Are Behavioural Disorders a separate nosological category of disorders? Shrirang Bakhle 1 1 Consulting Physician, Mumbai. E-mail ss.bakhle@gmail.com ABSTRACT The term Behavioural Disorders
More informationDecember 2014 MRC2.CORP.D.00011
This program is paid for by Otsuka America Pharmaceutical, Inc. and Lundbeck, LLC. The speaker is a paid contractor of Otsuka America Pharmaceutical, Inc. advice or professional diagnosis. Users seeking
More informationFrailty and Depression in Late Life
1 Frailty and Depression in Late Life Patrick J. Brown, PH.D Assistant Professor of Clinical Psychology in Psychiatry College of Physicians and Surgeons, Columbia University New York State Psychiatric
More informationHOW TO PREVENT COGNITIVE DECLINE.AT MCI STAGE?
EAMA CORE CURRICULUM HOW TO PREVENT COGNITIVE DECLINE.AT MCI STAGE? Sofia Duque Orthogeriatric Unit São Francisco Xavier Hospital Occidental Lisbon Hospital Center University Geriatric Unit, Faculty of
More informationLate Onset Depression Working Group. Chairs: Peter De Boer, PhD Patricia Capaccione, RPh February 20, 2018
Late Onset Depression Working Group Chairs: Peter De Boer, PhD Patricia Capaccione, RPh February 20, 2018 Objectives To explore the State of the Science in Late Onset Depression*** (LOD) 1. Identify the
More informationGenomind and The Genecept Assay
Genomind and The Genecept Assay A Growing Problem of Psychiatric Conditions One in four adults, approximately 61.5 M American adults suffer from mental illness 1 ; depression will become the largest health
More informationThe shift in nosology from the Diagnostic PROCEEDINGS FROM CHILDHOOD TO ADOLESCENCE: DIAGNOSIS AND COMORBIDITY ISSUES * Thomas J. Spencer, MD ABSTRACT
FROM CHILDHOOD TO ADOLESCENCE: DIAGNOSIS AND COMORBIDITY ISSUES * Thomas J. Spencer, MD ABSTRACT Attention-deficit/hyperactivity disorder (ADHD) tends to manifest differently in adolescents than in children,
More informationCognitive ageing and dementia: The Whitehall II Study
Cognitive ageing and dementia: The Whitehall II Study Archana SINGH-MANOUX NIH: R01AG013196; R01AG034454; R01AG056477 MRC: K013351, MR/R024227 BHF: RG/13/2/30098 H2020: #643576 #633666 Outline Lifecourse
More informationRisk Factor Reduction and Dementia Prevalence Deborah E. Barnes, PhD, MPH
Risk Factor Reduction and Dementia Prevalence Deborah E. Barnes, PhD, MPH Associate Professor Psychiatry and Epidemiology & Biostatistics University of California, San Francisco San Francisco VA Medical
More informationMental Health: Where Nutrition meets Psychiatry By Nicola Walters, Registered Dietitian
Mental Health: Where Nutrition meets Psychiatry By Nicola Walters, Registered Dietitian Key Focus Areas Overview of Global & SA Statistics Analysis of the Evidence Sugar & Refined Carbohydrates Fat: dietary
More informationErin Cullnan Research Assistant, University of Illinois at Chicago
Dr. Moises Gaviria Distinguished Professor of Psychiatry, University of Illinois at Chicago Director of Consultation Liaison Service, Advocate Christ Medical Center Director of the Older Adult Program,
More informationA Dynamic Model of Care for Late Onset Cognitive Impairment. Linda CW Lam Department of Psychiatry The Chinese University of Hong Kong
A Dynamic Model of Care for Late Onset Cognitive Impairment Linda CW Lam Department of Psychiatry The Chinese University of Hong Kong Outline The pathogenesis of Late life cognitive impairment A framework
More informationAging with Bipolar Disorder. Neha Jain, MD, FAPA Assistant Professor of Psychiatry, UConn Health
Aging with Bipolar Disorder Neha Jain, MD, FAPA Assistant Professor of Psychiatry, UConn Health Objectives Define bipolar disorder in the elderly Review comorbidities How does it differ from bipolar in
More informationComorbidity of Depression and Other Diseases
Comorbidity of Depression and Other Diseases JMAJ 44(5): 225 229, 2001 Masaru MIMURA Associate Professor, Department of Psychiatry, Showa University, School of Medicine Abstract: This paper outlines the
More informationJ. John Mann, MD DIRECTOR OF THE MOLECULAR IMAGING AND NEUROPATHOLOGY DIVISION COLUMBIA UNIVERSITY NEW YORK STATE PSYCHIATRIC INSTITUTE
J. John Mann, MD DIRECTOR OF THE MOLECULAR IMAGING AND NEUROPATHOLOGY DIVISION COLUMBIA UNIVERSITY NEW YORK STATE PSYCHIATRIC INSTITUTE PAUL JANSSEN PROFESSOR OF TRANSLATIONAL NEUROSCIENCE DEPARTMENT OF
More informationUSE OF BIOMARKERS TO DISTINGUISH SUBTYPES OF DEMENTIA. SGEC Webinar Handouts 1/18/2013
Please visit our website for more information http://sgec.stanford.edu/ SGEC Webinar Handouts 1/18/2013 2013 WEBINAR SERIES STATE OF THE SCIENCE: DEMENTIA EVALUATION AND MANAGEMENT AMONG DIVERSE OLDER
More informationNATIONAL ACADEMY OF NEUROPSYCHOLOGY
NATIONAL ACADEMY OF NEUROPSYCHOLOGY CLINICAL PSYCHOPHARMACOLOGY SYLLABUS OVERVIEW The goal of this CE is to provide participants with our current understanding of the molecular sites and mechanisms of
More informationDifferentiating Unipolar vs Bipolar Depression in Children
Differentiating Unipolar vs Bipolar Depression in Children Mai Uchida, M.D. Director, Center for Early Identification and Prevention of Pediatric Depression Massachusetts General Hospital Assistant Professor
More informationNon Alzheimer Dementias
Non Alzheimer Dementias Randolph B Schiffer Department of Neuropsychiatry and Behavioral Science Texas Tech University Health Sciences Center 9/11/2007 Statement of Financial Disclosure Randolph B Schiffer,,
More informationThe current state of healthcare for Normal Aging, Mild Cognitive Impairment, & Alzheimer s Disease
The current state of healthcare for Normal Aging, g, Mild Cognitive Impairment, & Alzheimer s Disease William Rodman Shankle, MS MD FACP Director, Alzheimer s Program, Hoag Neurosciences Institute Neurologist,
More informationPSYCHOTROPIC MEDICATION UTILIZATION PARAMETERS FOR CHILDREN AND YOUTH IN FOSTER CARE
PSYCHOTROPIC MEDICATION UTILIZATION PARAMETERS FOR CHILDREN AND YOUTH IN FOSTER CARE Introduction and General Principles April 2017 Adapted for New Mexico from with permission from the Texas Department
More informationThe added value of the IWG-2 diagnostic criteria for Alzheimer s disease
The added value of the IWG-2 diagnostic criteria for Alzheimer s disease Miami, January 2016 Bruno Dubois Head of the Dementia Research Center (IMMA) Director of INSERM Research Unit (ICM) Salpêtrière
More informationTargeting depression after ARDS. Neill Adhikari Sunnybrook Health Sciences and University of Toronto 29 October 2012
Targeting depression after ARDS Neill Adhikari Sunnybrook Health Sciences and University of Toronto 29 October 2012 None Conflicts of interest Objectives Review epidemiology of depression after ARDS Review
More informationLithium in bipolar disorders.
Lithium in bipolar disorders. S. Mehdi Samimi Ardestani M.D. Department of Psychiatry, Shahid Beheshti University of Medical Science, Behavioral science research center Iranian psychiatric association,
More informationAdvocating for people with mental health needs and developmental disability GLOSSARY
Advocating for people with mental health needs and developmental disability GLOSSARY Accrued deficits: The delays or lack of development in emotional, social, academic, or behavioral skills that a child
More informationDeborah Kacanek, Konstantia Angelidou, Paige L. Williams, Miriam Chernoff, Kenneth Gadow, Sharon Nachman, The IMPAACT P1055 Study Team
Psychiatric disorder symptoms are associated with longitudinal changes in antiretroviral (ARV) non-adherence in perinatally HIV-infected youth in the US: Results from IMPAACT P1055 Deborah Kacanek, Konstantia
More informationCLINICAL NEUROPSYCHOLOGY Course Syllabus, Spring 2018 Columbia University
CLINICAL NEUROPSYCHOLOGY Course Syllabus, Spring 2018 Columbia University Instructor: E mett McCaskill, PhD Office: 356 SchExt, Columbia University; 415-O Milbank Hall, Barnard College Email: e.mccaskill@columbia.edu
More informationPrevalence and Pattern of Psychiatric Disorders in School Going Adolescents
The International Journal of Indian Psychology ISSN 2348-5396 (e) ISSN: 2349-3429 (p) Volume 4, Issue 3, No. 100, DIP 18.01.074/20170403 ISBN: 978-1-387-00243-6 http://www.ijip.in April-June, 2017 Prevalence
More informationTHE NEUROBIOLOGY OF ANXIETY DISORDERS
THE NEUROBIOLOGY OF ANXIETY DISORDERS By Richard E. Powers, MD Overview Anxiety is a biological response that protects humans from harm. All human beings experience normal anxiety at some level; however,
More informationCSF Aβ1-42 predicts cognitive impairment in de novo PD patients
CSF Aβ1-42 predicts cognitive impairment in de novo PD patients Mark Terrelonge MPH *1, Karen Marder MD MPH 1, Daniel Weintraub MD 2, Roy Alcalay MD MS 1 1 Columbia University Department of Neurology 2
More informationYouth Mental Health and 22q11
Youth Mental Health and 22q11 Cameron S. Carter M.D. Director Center for Neuroscience U.C. Davis Early Diagnosis & Preventative Treatment Clinic (EDAPT) UC Davis Department of Psychiatry of Mental Health
More informationCUA. THE CATHOLIC UNIVERSITY OF AMERICA National Catholic School of Social Service Shahan Hall Washington, DC Fax
1 CUA THE CATHOLIC UNIVERSITY OF AMERICA National Catholic School of Social Service Shahan Hall Washington, DC 20064 202-319-5458 Fax 202-319-5093 SSS 572 Human Development and Psychopathology Spring 2012
More informationCLINICAL NEUROPSYCHOLOGY Course Syllabus, Spring 2015 Columbia University
CLINICAL NEUROPSYCHOLOGY Course Syllabus, Spring 2015 Columbia University Instructor: E mett McCaskill, PhD Office: 356 SchExt, Columbia University; 415-O Milbank Hall, Barnard College Email: ew87@columbia.edu
More informationSleep and Neurocognitive aging in Population based studies
Sleep and Neurocognitive aging in Population based studies Alberto Ramos, MD,MSPH, FAASM Associate Professor of Neurology University of Miami Health System Miller School of Medicine aramos@med.miami.edu
More informationWhite matter hyperintensities correlate with neuropsychiatric manifestations of Alzheimer s disease and frontotemporal lobar degeneration
White matter hyperintensities correlate with neuropsychiatric manifestations of Alzheimer s disease and frontotemporal lobar degeneration Annual Scientific Meeting Canadian Geriatric Society Philippe Desmarais,
More informationDiffusing the Stress in Financial Distress: The Intersection of Bankruptcy and Mental Health
Diffusing the Stress in Financial Distress: The Intersection of Bankruptcy and Mental Health Moderator: Hon. Laura Taylor Swain (S.D. N.Y.), New York, NY Panelists: Prof. Richard A. Friedman, M.D., Weill
More informationCHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XV, 2013 INDEX
A acceptance and commitment therapy Posttraumatic Stress, 69 ADHD Adjunctive Fatty Acids, 5 Adjunctive Guanfacine Pharmacokinetics, 27 Amantadine, 21 Atomoxetine, 23 Cancer Risk, 31 CBT for Comorbid Anxiety,
More informationMental Health Problems in Individuals with Prenatal Alcohol Exposure and Fetal Alcohol Spectrum Disorder
Mental Health Problems in Individuals with Prenatal Alcohol Exposure and Fetal Alcohol Spectrum Disorder Presenter: Date: Jacqueline Pei, R. Psych., PhD Carmen Rasmussen, PhD May 5, 2009 The FASD Learning
More informationThe Neurobiology of Mood Disorders
The Neurobiology of Mood Disorders J. John Mann, MD Professor of Psychiatry and Radiology Columbia University Chief, Department of Neuroscience, New York State Psychiatric Institute Mood Disorders are
More informationDifferentiating MDD vs. Bipolar Depression In Youth
Differentiating MDD vs. Bipolar Depression In Youth Mai Uchida, M.D. Staff Physician Clinical and Research Programs in Pediatric Psychopharmacology Massachusetts General Hospital Disclosures Neither I
More informationOther Disorders Myers for AP Module 69
1 Other s Myers for AP Module 69 Describe the general characteristics of somatic symptom disorders. How does culture influence people s expression of physical complaints? Compare the symptoms of conversion
More informationTITLE: Endophenotypes of Dementia Associated with Traumatic Brain Injury in Retired Military Personnel
Award Number: W81XWH 12 1 0581 TITLE: Endophenotypes of Dementia Associated with Traumatic Brain Injury in Retired Military Personnel PRINCIPAL INVESTIGATOR: Kristine Yaffe, MD CONTRACTING ORGANIZATION:
More informationWebinar: How Do We Measure Mental Illness & Addictions at a Population Level?
Webinar: How Do We Measure Mental Illness & Addictions at a Population Level? Jürgen Rehm Centre for Addiction and Mental Health, Toronto, Canada Dalla Lana School of Public Health and Department of Psychiatry,
More informationLa demenza si può predire, prevenire e quindi trattare
ALZHEIMER: I NUOVI ORIZZONTI DELLA CURA AFFRONTARLO PRESTO AFFRONTARLO INSIEME Biella, 29 settembre 2010 La demenza si può predire, prevenire e quindi trattare Innocenzo Rainero, MD PhD Associate Professor
More informationComparison of the latency time of selective serotonin reuptake inhibitors and serotonin-noradrenaline reuptake inhibitors
Journal of Medicine and Medical Science Vol. 2(9) pp. 1085-1092, September 2011 Available online@ http://www.interesjournals.org/jmms Copyright 2011 International Research Journals Full Length Research
More informationReview: Psychosocial assessment and theories of development from N141 and Psych 101
Unit III Theory and Practice of Psychiatric Nursing REQUIRED READINGS AND ACTIVITIES Related Activities Assignments Review: Psychosocial assessment and theories of development from N141 and Psych 101 Anxiety,
More information4/28/2017. Aging with Down Syndrome. Second Annual USC UCEDD Community Education Conference May 19, 2017
Aging with Down Syndrome Second Annual USC UCEDD Community Education Conference May 19, 2017 Linda D. Nelson, M.Ed., Ed.S., Ph.D., ABN Board Certified Clinical Neuropsychologist Professor, Emerita, of
More informationThe real pathology of Depression
The real pathology of Depression Dr André F Joubert MB,ChB; M.Med(Psych); D.Med Cape Town, South Africa Copenhagen, Denmark Depression hypothesis Joubert In preparation Depression hypothesis Joubert In
More informationBehavioral Health Treatment in a Primary Care Setting
Behavioral Health Treatment in a Primary Care Setting Andrew J. McLean, MD, MPH Medical Director, ND DHS Chair, Psychiatry and Behavioral Science, UNDSMHS ajmclean@nd.gov Objectives Understand the importance
More informationBringing. to patients with depression
Bringing to patients with depression Hope is knowing remission from depression is possible Depression is a serious illness that affects approximately 350 million people worldwide. 1 While medications may
More informationChanging diagnostic criteria for AD - Impact on Clinical trials
Changing diagnostic criteria for AD - Impact on Clinical trials London, November 2014 Bruno Dubois Head of the Dementia Research Center (IMMA) Director of INSERM Research Unit (ICM) Salpêtrière Hospital
More informationRANZCP 2010 AUCKLAND, NEW ZEALAND
RANZCP 2010 AUCKLAND, NEW ZEALAND Dr Veronica Stanganelli et al. RANZCP 2010 1 INTRODUCTION Bipolar disorder within young people has been debated for years. It is still controversial in DSM V (1), whether
More informationUSAAA 2007 International Conference. Autism- you'll never see it the same way again
J. Michael Uszler, MD USAAA 2007 International Conference www.drspectscan.com Autism- you'll never see it the same way again Do you have a concern that your brain is not working right? Are you having trouble
More informationFinal Report of Activity February 21 st, 2006 to April 30 th, 2006 CHEO Grant 052
Final Report of Activity February 21 st, 2006 to April 30 th, 2006 CHEO Grant 052 1- Title of Study: The prevalence of neuropsychiatric disorders in children and adolescents on an inpatient treatment unit:
More informationA randomized controlled clinical trial of Citalopram versus Fluoxetine in children and adolescents with obsessive-compulsive disorder (OCD)
Eur Child Adolesc Psychiatry (2009) 18:131 135 DOI 10.1007/s00787-007-0634-z ORIGINAL CONTRIBUTION Javad Alaghband-Rad Mitra Hakimshooshtary A randomized controlled clinical trial of Citalopram versus
More informationDisruptive behaviour disorders Oppositional defiant disorder (ODD) / Conduct disorder (CD)
Disruptive behaviour disorders Oppositional defiant disorder (ODD) / Conduct disorder (CD) Professor Alasdair Vance Head, Academic Child Psychiatry Department of Paediatrics University of Melbourne Royal
More informationLongest running mental health survey series using consistent methods
Longest running mental health survey series using consistent methods Adult household Adult household Adult follow-up Adult household Adult household 993 2000 2002 2007 2014 Surveys of specific populations
More informationSuicide Ideation, Planning and Attempts: Results from the Israel National Health Survey
Isr J Psychiatry Relat Sci Vol 44 No. 2 (2007) 136 143 Suicide Ideation, Planning and Attempts: Results from the Israel National Health Survey Daphna Levinson, PhD, 1 Ziona Haklai, MA, 1 Nechama Stein,
More informationMood Disorders and Addictions: A shared biology?
Mood Disorders and Addictions: A shared biology? Dr. Paul Stokes Clinical Senior Lecturer, Centre for Affective Disorders, Department of Psychological Medicine Disclosures No relevant disclosures: No paid
More informationAEVI-001: SAGA Trial in mglur+ ADHD
AEVI-001: SAGA Trial in mglur+ ADHD Topline Results March 20, 2017 2017, Aevi Genomic Medicine Forward-Looking Statement This presentation includes certain estimates and other forward-looking statements
More informationPsychiatric problems common in siblings of people with autism
NEWS Psychiatric problems common in siblings of people with autism BY ANN GRISWOLD 23 JUNE 2016 Psychiatric conditions crop up more than twice as often in families that include a child with autism as in
More information10/19/2017. Cognitive changes of normal aging What is normal, what is not? Dementia, Alzheimer s what s the difference?
Cognitive changes of normal aging What is normal, what is not? Dementia, Alzheimer s what s the difference? Mild Cognitive Impairment and Pre Alzheimer s disease OK, so what can I do? Cognitive Aging:
More informationAlzheimer's Disease An update on diagnostic criteria & Neuropsychiatric symptoms. l The diagnosis of AD l Neuropsychiatric symptoms l Place of the ICT
Alzheimer's Disease An update on diagnostic criteria & Neuropsychiatric symptoms State of the art lecture March 4-2012 Philippe H Robert, Philippe Nice - France Robert The diagnosis of AD Neuropsychiatric
More informationAttention-Deficit/Hyperactivity Disorder in Children and Adults Advances in Psychotherapy
Attention-Deficit/Hyperactivity Disorder in Children and Adults Advances in Psychotherapy Questions from chapter 1 1) For a diagnosis of ADHD, some symptoms that cause impairment must be present before
More informationDM-ID and Other Tools to Assist Clinical Judgment
and Other Tools to Assist Clinical Judgment Ann R. Poindexter, M.D. Overview of the Diagnostic Manual for Persons with Intellectual Disabilities Robert J. Fletcher, DSW, ACSW, FAAIDD Chief Editor of Founder
More informationDr Keith Ganasen Department of Psychiatry UCT
Dr Keith Ganasen Department of Psychiatry UCT A. Significantly subaverage intellectual functioning: an IQ of approximately 70 or below on an individually administered IQ test B. Concurrent deficits or
More informationPsychological Disorders. Schizophrenia Spectrum & Other Psychotic Disorders. Schizophrenia. Neurodevelopmental Disorders 4/12/2018
Psychological s Schizophrenia Spectrum & Other Psychotic s Schizophrenia Spectrum & Other Psychotic s 0Presence of delusions, hallucinations, disorganized thinking/speech, disorganized or abnormal motor
More informationClinical Trial Designs for RCTs focussing on the Treatment of Agitation in people with Alzheimer s disease
Clinical Trial Designs for RCTs focussing on the Treatment of Agitation in people with Alzheimer s disease Professor Clive Ballard Dr Byron Creese University of Exeter, UK Guardian guide for 2018: Top
More informationInformed Consent in Child and Adolescent Psychiatry Research
Informed Consent in Child and Adolescent Psychiatry Research Kathryn R. Cullen, M.D. Assistant Professor and Division Director, Child and Adolescent Psychiatry Department of Psychiatry University of Minnesota
More informationEarly Onset Dementia From the background to the foreground
Early Onset Dementia From the background to the foreground Dr Jeremy Isaacs Consultant Neurologist St George s Hospital Excellence in specialist and community healthcare Themes of my talk The early onset
More informationدمانس های اتوایمون دکتر رضائی طلب نورولوژیست آذر 95
دمانس های اتوایمون دکتر رضائی طلب نورولوژیست آذر 95 Definition: Dementia According the DSM-5, dementia is defined as significant acquired cognitive impairment in one or more cognitive domains (eg, learning
More informationAntidepressants. Professor Ian Jones May /WalesMentalHealth
Antidepressants Professor Ian Jones May 2017 www.ncmh.info @ncmh_wales /WalesMentalHealth 029 2074 4392 info@ncmh.info We identified 19 740 pregnancies exposed to an antidepressant at some point during
More informationAnosognosia, or loss of insight into one s cognitive
REGULAR ARTICLES Anosognosia Is a Significant Predictor of Apathy in Alzheimer s Disease Sergio E. Starkstein, M.D., Ph.D. Simone Brockman, M.A. David Bruce, M.D. Gustavo Petracca, M.D. Anosognosia and
More information8/14/2018. The Evolving Concept of Alzheimer s Disease. Epochs of AD Research. Diagnostic schemes have evolved with the research
The Evolving Concept of Alzheimer s Disease David S. Geldmacher, MD, FACP Warren Family Endowed Chair in Neurology Department of Neurology UAB School of Medicine Epochs of AD Research Epoch Years Key Event
More informationCurriculum Vitae, Michael J. Downing, M.D.
CONTACT INFORMATION: Site Selection and Information: Bobbie Theodore, Alliance Director Tel. (916) 939-6696 Fax (208) 575-3169 Email: clinicaltrials@alliancesites.com PROFESSIONAL AFFILIATIONS: Michael
More informationSUMMARY AND DISCUSSION
Risk factors for the development and outcome of childhood psychopathology SUMMARY AND DISCUSSION Chapter 147 In this chapter I present a summary of the results of the studies described in this thesis followed
More informationRethinking Maternal Mental Health Screening: Is There a Better Approach?
Rethinking Maternal Mental Health Screening: Is There a Better Approach? Mark Erickson, MD Medical Director of Quality Improvement, Behavioral Services Division Sarah Switzer, LCSW, CDCI Behavioral Health
More informationBrain Plasticity: The Effects of Antidepressants on Major Depression
Brain Plasticity: The Effects of Antidepressants on Major Depression J. John Mann MD Paul Janssen Professor of Translational Neuroscience Columbia University Director, Division of Molecular Imaging and
More information